Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine for Hemodynamic Stability and Opioid Requirement in Pulmonary Hydatid Cyst Surgery
IRCT20250626066260N1Phase 3Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Feb 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of dexmedetomidine in Pulmonary cystic echinococcosis (PCE), sponsored by Mashhad University of Medical Sciences. Primary endpoints: Hemodynamic stability during pulmonary hydatid cyst surgery and Opioid requirement in pulmonary hydatid cyst surgery. Started Feb 2026; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
Pulmonary cystic echinococcosis (PCE)
Beyond the preview
Go deeper on IRCT20250626066260N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250626066260N1.